Barrantes LC, Banard CM, Maitland RR

Language: Spanish
References: 13
Page: 73-76
PDF size: 89.49 Kb.

ABSTRACT

Gastric cancer is one of the ilInesses that cause the most number of death around the world, due to malignant tumour. The dump continues to be the most common localization, eventhough, a significant increase of cardias injuries can be observed. Rectal cancer is the most frequent tumor of the digestive tract. Primary tumours such as peritoneum and the peritoneal carcinomatosis or local interabdominal dissemination, are tumours of diverse origins and they normally show up through a variable of clinical manifestations, or of very difficult terapeutic control, usually related to a fatal prognosis or condition. It is likewise common to see metastasis appear in the patients peritoneal cavity, with carcinoma in the digestive system. This phenomenous takes place because of the liberation of malignant cells in the abdominal cavity, through the invation of the serous or during the manipulation of the organ by the surgeon during the surgical act. Clinic and anatomopathologic studies made to a male patient of 62 years, who entered the San Juan de Dios Hospital with an abdominal tumor, digestive symptoms, ascites, cervical adenopathy and collar bone discovered the following:
- Computerized axial tomography, that evidence gastric tumour, ascitis and retroperitoneal lump, with 125 —Ca and a high amount of carcinogen antigen.
- Abdominal ultrasound test that reports nodule injuries in epigastric peritonium, nodular swellings of the mesentery and gastric swelling in both body and dump.
- Surgical pathology studies that reports an adenocarcinoma a bit different and o esophagastritisduodenoscopy, where it is possible to observe a mamal lump in the sub-cardial region.

REFERENCES

1. Bergman JF, Bridart JM, George M, Beaugrand M, Levy VG. Bohous C. Elevation of CA 125 in patients whith bening and malignan ascitis Cancer 1987; 59:213-17.

2. Bottomley A. Metastatic colorectal cancer: treatment challenges and quality of lite. Lancet 2002; 359 (4): 1537-8.

3. Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis from gynecological malignancies: a propective study of prognosis factors. Cancer 1989; 63:364-7.

4. Levitt RG, Sagell SS, Stanley RJ. Detection of neoplasic involvement of the mesentery and omentum by computed tomography. ARJAm J Roentgenol.1978;131(5):835-41.

5. Marrero A, Rodríguez R, Honorato A, Palomino A, Velasco M, Hernández O, et al. Radicabilidad en cáncer gástrico: Orientación pronóstica. Revista Venezolana de Oncología. 1999;11(4):116-132

6. O’Brien Tj, Tanimoto Hi, Konishi J, Gee M. More than 15 years of CA 125: what is know about the antigen, its structure and its function Int J Biol Markers 1998; 131:188-95.

7. Rodríguez GO, Estadificación del cáncer laparóscopico. Gaceta Médica Caracas. 2001;109 (3):322-31

8. Sampson JA. Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathologhy 1931; 7:423-43.

9. Sticca RP. Peritoneal carcinomatosis: a final frontier. Ann Surgery Oncol 2003; 10 (5): 484-5.

10. De Bree E, Wiitkamp A, Zoetmulder FAN. Intraperitoneal chemotherapy for colorectal cancer. Review article. J Surg Oncol 2002; 79: 46-61.

11. Gómez Portilla, A., Cedoya, I., López de Tejeda, I. et al. Peritoneal carcinomatosis of colorectal origin.Current treatment: Review and update. Revista Española de enfermedades digestivas. 2005: 97(10):.716-737.

12. Glehen O, Kwiatkoski M, Sugarbaker PH, Elias D, Levine EA, Gilly FN, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer. A multi-institutional study of 506 patients. J Clin Oncol 2004; 22 (3): 284-329.

13. Kindler HL. Shulman Kl. Metastatic colorectal cancer. Current Treatment Options in Oncology 2001; 2:459-71.